Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Publication year range
1.
Ann Pharmacother ; 34(11): 1273-5, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11098341

ABSTRACT

OBJECTIVE: To report a case of changes documented by magnetic resonance imaging (MRI) of the head probably due to accumulation of metronidazole in a patient with liver dysfunction. CASE SUMMARY: A 34-year-old Hispanic man with cirrhosis and hepatitis C being treated with metronidazole for Bacteroides fragilis meningitis and bacteremia developed ataxia, disorientation, and peripheral neuropathy. An MRI at the time meningitis was diagnosed was negative. After the patient received > 60 g of metronidazole, an MRI revealed increased signal intensity below, behind, and lateral to the fourth ventricle. Concomitant metronidazole serum concentration was toxic at 35.1 micrograms/mL. DISCUSSION: This is the second reported case of metronidazole-induced MRI changes. Metronidazole is known to accumulate in patients with liver dysfunction and can cause peripheral neuropathy and central nervous system (CNS) dysfunction; these effects may take up to two years to completely resolve. CONCLUSIONS: Metronidazole dosages should be reduced in patients with liver dysfunction to prevent the accumulation of metronidazole, which can lead to CNS dysfunction and peripheral neuropathy.


Subject(s)
Anti-Infective Agents/adverse effects , Brain/drug effects , Magnetic Resonance Imaging , Meningitis, Bacterial/drug therapy , Metronidazole/adverse effects , Peripheral Nervous System Diseases/chemically induced , Adult , Anti-Infective Agents/metabolism , Hepatitis C/complications , Hepatitis C/metabolism , Humans , Liver Cirrhosis/complications , Liver Cirrhosis/metabolism , Male , Meningitis, Bacterial/complications , Metronidazole/metabolism , Peripheral Nervous System Diseases/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL